A biology-based mathematical model indicates why COVID-19 outcomes vary widely and how therapy can be tailored to match the needs of specific patient groups.
Jan. 5, 2021 • ~6 min
covid-19 coronavirus pandemic health-medicine brigham-and-womens-hospital massachusetts-general-hospital mgh rakesh-k-jain university-of-cyprus
Adding the blood-pressure drug losartan to the intensive chemo and radiation protocol for treating locally advanced pancreatic cancer allowed complete removal of the tumor in 61 percent of trial participants and significantly improved survival rates.
May 30, 2019 • ~5 min
health-medicine massachusetts-general-hospital mgh blood-pressure carlos-fernandez-del-castillo janet-murphy jennifer-wo losartan pancreatic-cancer rakesh-k-jain theodore-hang